← Back to Search

Adherence Intervention for Rheumatic Diseases

N/A
Recruiting
Led By Kai Sun, MD, MS
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months
Awards & highlights

Study Summary

This trial will test a new way to help people with rheumatic diseases better follow their medication plan. It'll assess whether it works and how well it's accepted.

Who is the study for?
This trial is for patients with rheumatic diseases who are currently prescribed medication and treated at Southpoint Rheumatology. It's not open to new patients, those without prescriptions for rheumatic conditions, or anyone lacking pharmacy refill data.Check my eligibility
What is being tested?
The study is testing a clinician-led program designed to help patients with various rheumatic diseases take their medications more reliably. The focus is on seeing if the approach works well and if people like it.See study design
What are the potential side effects?
Since this trial focuses on improving medication adherence rather than a specific drug, there aren't direct side effects from interventions being tested. However, regular medication side effects apply.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Feasibility
Secondary outcome measures
Acceptability
Acceptability, as measured by the percentage of patients who report a positive feeling after having an adherence conversation with their providers
Change in medication adherence
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Clinicians in this arm will be trained to conduct the adherence intervention in general rheumatology clinic with all follow up patients with a chronic rheumatic disease. Patients seen by these clinicians will contribute to the outcome data collection.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,364 Previous Clinical Trials
3,420,630 Total Patients Enrolled
2 Trials studying Rheumatic Diseases
20,146 Patients Enrolled for Rheumatic Diseases
Kai Sun, MD, MSPrincipal InvestigatorDuke Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots to become part of this experiment?

"The details on clinicaltrials.gov indicate that recruitment for this specific trial ceased after the information was last updated on August 25th 2023. Nevertheless, there are 41 alternative medical studies currently seeking participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Medication Adherence in Rheumatic Diseases
2024. "Medication Adherence in Rheumatic Diseases". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06018350.
~8 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top